| 名稱(chēng) | β-thalassemia mutation Reference Standard Ⅴ |
| 型號(hào) | CBPD0005 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | β-thalassemia mutation Reference Standard Ⅴ |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 科佰生物提前祝大家中秋快樂(lè)，闔家團(tuán)圓！
- CSF1R細(xì)胞篩選模型
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 認(rèn)識(shí)下北京細(xì)胞庫(kù)的質(zhì)量管理要求
- 為什么STR鑒定對(duì)于ATCC細(xì)胞系來(lái)說(shuō)很重要
- 能量平衡的重要靶點(diǎn)——CRF1R和CRF2R
- OXTR細(xì)胞篩選模型
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 認(rèn)識(shí)一下北京細(xì)胞庫(kù)的檢測(cè)項(xiàng)目
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0005β-thalassemia mutation Reference Standard Ⅴ
- 詳細(xì)內(nèi)容
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Mutation 1 | Variation site: Codon 39(C>T) |
| DNA Change: c.118C>T | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248004G>A | |
| Transcript: NM_000518.5 | |
| Mutation 2 | Variation site: IVS-II-1(G>A) |
| DNA Change: c.315+1G>A | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5247806C>T | |
| Transcript: NM_000518.5 | |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. Codon 39(C>T) Heterozygous
Figure 2. IVS-II-1(G>A) Heterozygous |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)